February 1, 2017
Allergan completes $2.9 LifeCell buy, boosts up its plastic surgery business
Allergan has completed the $2.9 billion purchase of Acelity’s subsidiary LifeCell, adding commercial products to its regenerative medicine portfolio, and LifeCell’s innovative manufacturing capabilities and its R&D operations, based in New Jersey.